RESEARCH-USE BIOSIMILAR ANTIBODY
Tralokinumab
Monoclonal antibody · IgG4
Tralokinumab (CAT354) is a humanized IgG4 monoclonal antibody that specifically binds to and neutralizes IL-13. Tralokinumab can be used in the research of diseases such as asthma, atopic dermatitis, and pulmonary fibrosis.
TARGETIL13
YMonoclonal antibody
CATALOGSC-BS-088
CATALOG NUMBERSC-BS-088
MOLECULAR WEIGHTApprox. 144.14 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Tralokinumab (CAT354) is a humanized IgG4 monoclonal antibody that specifically binds to and neutralizes IL-13. Tralokinumab can be used in the research of diseases such as asthma, atopic dermatitis, and pulmonary fibrosis.
Tralokinumab is a recombinant research-use antibody directed against IL13.